Companion Diagnostic Assays For Endothelin Receptor Antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 22, 2010
app pub date -
Jan 22, 2009
filing date -
Jan 22, 2009
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Methods for identifying cancer patients eligible to receive endothelin receptor antagonist therapy and for monitoring patient response to endothelin receptor antagonist therapy comprise assessment of the expression levels of at least one of PAI-1, uPA, TGFbeta2, IL-6, IL-8 and OPG in a patient tissue sample. The methods of the invention allow more effective identification of patients to receive endothelin receptor antagonist therapy and of determination of patient response to the therapy.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
ABBOTT MOLECULAR INC | 1300 E TOUHY DES PLAINES IL 60018 |
International Classification(s)

- 2009 Application Filing Year
- C12Q Class
- 2344 Applications Filed
- 1150 Patents Issued To-Date
- 49.07 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Lesniewski, Richard R | Pleasant Prairie, US | 10 | 67 |
# of filed Patents : 10 Total Citations : 67 | |||
Semizarov, Dimitri | Chicago, US | 20 | 63 |
# of filed Patents : 20 Total Citations : 63 | |||
Van, Sant Charles L | Grayslake, US | 2 | 12 |
# of filed Patents : 2 Total Citations : 12 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 6 Citation Count
- C12Q Class
- 6.50 % this patent is cited more than
- 15 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
